CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2018

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Preparation of hybrid Nano-ciprofloxacin and determination its inhibition activity against E. coli isolated from urinary tract infection patients in holy Karbala city

Author: 
Israa H. Al-Zubaidy, Saife D. Al-Ahmer and Ali A. Al-Ghanimi
Subject Area: 
Life Sciences
Abstract: 

Background: Urinary tract infections are the most common infections after upper respiratory tract infections E. coli caused 20% of urinary tract infection and it was responsible for 1/3 of the infections. Nanoparticles (NPs) in general have many properties that are different from those of traditionally used materials. They have dimensions typically below 100 nm, which allows them to reach specific sites inside the body and even to be permeable to tissues and cells. Therefore, they can deliver the drugs in active forms at sites that conventional drugs may not reach by themselves and thus minimize the undesirable side effects. Layered double hydroxides (LDHs) as one of the inorganic delivery nanoparticles have recently been receiving considerable attentions. Ciprofloxacin is a broad-spectrum antibiotic of the fluoroquinolone class. It is active against both Gram-positive and Gram-negative bacteria and it is recognized as one of the most effective antibiotics of the quinolone drug class and has been used for the treatment of urinary tract infections. Aims and objectives: The aims of present study were to prepare hybrid nanoan-ciprofloxacin and characterize by spectroscopic methods, and determine its inhibitory activity against the E. coli isolates caused the urinary tract infection in this study. Materials and Methods: In this study urine samples from 75 patients clinically diagnosed with urinary tract infection were collected into sterile screw capped container and used for culture, Gram staining, API E20, antibiotic sensitivity test and singleplex PCR methods. PCR was performed with primer pair targeted to the PhoA gene of E. coli. Hybrid nano-antibiotic represented by the Mg/Al-Ciprofloxacin-LDH was prepared by using the direct ion exchange method between the free ciprofloxacin antibiotic and Mg/Al-LDH carrier, and then the hybrid nano-ciprofloxacin was characterized by spectroscopic methods include FTIR, XRD and AFM. Results: Out of 75 samples, 27(36%) samples have been detected for E. coli depending on the morphologic and biochemical characteristics of this bacterium on the nutrient agar, MacConky agar, blood base agar and EMB agar, as well as Gram stain and API E20. The antibiotic sensitivity test was showed different sensitivity patterns of E. coli isolates against the different types of antibiotics varied from marked sensitive pattern against imipenem and meropenem, to moderate sensitive pattern against ciprofloxacin, norfloxacin, levofloxacin, nitrofurantoin and amikacin, in addition, to the marked resistance pattern toward ampicillin, ticarcillin, amoxicillin-clavanic acid and piperacillin. The singlplex PCR positive samples were identified by presence of ~903bp amplicon of the PhoA gene. The results of FTIR, XRD and AFM methods of nano-ciprofloxacin characterization indicted that this prepared nano-antibiotic was hybrid nano-ciprofloxacin (Mg/Al-Ciprofloxacin-LDH). The results of inhibition activity of both free ciprofloxacin and hybrid nano-ciprofloxacin showed that these two forms of ciprofloxacin revealed highest inhibition activity against two E. coli isolates (IS8 and IS10) with diameter of inhibition zone 40 and 42 mm, respectively. Whereas the E. coli isolates IS1and IS2 were the least affected isolates by the inhibition activity of these two forms of cirofloxacin with diameter of inhibition zone 38 and 35 mm, respectively. Conclusion: Using of hybrid nano-antibiotics resulting from loaded of different antibiotics on LDHs carrier could be represented a promising future tool to treat and control urinary tract infection and other different bacterial infections.

PDF file: 

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran